Skip to main content

Advertisement

SpringerLink
Log in

Autoimmune Hepatitis and Thyroiditis Associated with Rifampin and Pyrazinamide Prophylaxis: An Unusual Reaction

  • CASE REPORT
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Weir E, Fisman DN: Latent tuberculosis: revised treatment guidelines. CMAJ 169:937–938, 2003

    PubMed  Google Scholar 

  2. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection—New York and Georgia, 2000. Morb Mortal Wkly Rep 50:289–291, 2001

  3. Jasmer RM, Saukkonen JJ, Blumberg HM, et al. : Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: A multicenter clinical trial. Ann Intern Med 137:640–647, 2002

    PubMed  CAS  Google Scholar 

  4. MMWR Update: Adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for the treatment of latent infection—United States, 2003, Morb Mortal Wkly Rep, 52, 735–739, 2003

  5. Lewis J, Zimmerman H: Drug-induced autoimmune liver disease. In Autoimmune Liver Diseases. Krawitt EL, Wiesner RH, Nishioka (eds). New York, Elsevier Science BV, 1998, pp 627–649

    Google Scholar 

  6. Goldstein GB, Lam KC, Mistilis SP: Drug-induced chronic hepatitis. Am J Dig Dis 18:177–184, 1973

    PubMed  CAS  Google Scholar 

  7. Rodman JS, Deutsch DJ, Gutman SI: Methyldopa hepatitis: A report of six cases and review of the literature. Am J Med 60:941–948, 1976

    PubMed  CAS  Google Scholar 

  8. Arranto AJ, Sotaniemi WEA: Morphologic alteration in patients with α-methyldopa-induced liver damage after short and long term exposure. Scand J Gastroenterol 16:53, 1981

    Google Scholar 

  9. Sharp JR, Ishak KG, Zimmerman HJ: Chronic active hepatitis and severe hepatitis necrosis associated with nitrofurantoin. Ann Intern Med 92:14–19, 1980

    PubMed  CAS  Google Scholar 

  10. Selroos O, Edgren J: Lupus-like syndrome associated with pulmonary reaction to nitrofurantoin: Report of three cases. Acta Med Scand 197:125–129, 1975

    Article  PubMed  CAS  Google Scholar 

  11. Lundgren R, Back O, Wiman LG: Pulmonary lesions and autoimmune reactions after long term nitrofurantoin treatment. Scand J Resp Dis 56:208–212, 1975

    CAS  Google Scholar 

  12. Hatoff DE, Cohen M, Schweigart DF, et al. : Nitrofurantoin: Another cause of drug-induced chronic active hepatitis?. A report of a patient with HLA-B8 antigen. Am J Med 67:117–121, 1979

    CAS  Google Scholar 

  13. Iwarson S, Lindberg J, Lunden P: Nitrofurantoin induced chronic liver disease: clinical course and outcome of five cases. Scand J Gastroenterol 14:497–502, 1979

    PubMed  CAS  Google Scholar 

  14. Stricker BHCH, Blok APR, Claas FHJ, et al. : Hepatic injury associated with the use of nitrofurans: A clinical pathological study of 52 cases. Hepatology 8:599–606, 1988

    PubMed  CAS  Google Scholar 

  15. Gough A, Chapman S, Wagstaff K, et al. : Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. Br Med J 312:169–172, 1996

    CAS  Google Scholar 

  16. Malcolm A, Heap TR, Eckstein RP, et al. : Minocycline induced liver injury. Am J Gastroenterol 91:1641–1643, 1996

    PubMed  CAS  Google Scholar 

  17. Goldstein PE, Devier J, Cremer M: Acute hepatitis and drug-related lupus induced by minocycline treatment. Am J Gastroenterol 92:143–146, 1997

    Google Scholar 

  18. Bhat G, Jordan J Jr, Sokalski S, et al. : Minocycline-induced hepatitis with autoimmune features and neutropenia. J Clin Gastroenterol 27:74–75, 1998

    PubMed  CAS  Google Scholar 

  19. Goldstein NS, Bayati N, Silverman AL, et al. : Minocycline as a cause of drug-induced autoimmune hepatitis: Report of four cases and comparison with autoimmune hepatitis. Am J Clin Pathol 114:591–598, 2000

    PubMed  CAS  Google Scholar 

  20. Teitelbaum JE, Perez-Atayde AR, Cohen M, et al. : Minocycline-related autoimmune hepatitis: Case series and literature review. Arch Pediatr Adolesc Med 152:1132–1136, 1998

    PubMed  CAS  Google Scholar 

  21. Abe M, Furukawa S, Takayama S, et al. : Drug-induced hepatitis with autoimmune features during minocycline therapy. Intern Med 42:48–52, 2003

    PubMed  Google Scholar 

  22. Pariente EA, Hamoud A, Godfain D, et al. : Clometacin hepatitis. Retrospective study of 30 cases. A model of drug-induced autoimmune hepatitis?. Gastroenterol Clin Biol 13:769–774, 1989

    CAS  Google Scholar 

  23. Pessayre D, Degos F, Feldmann G, et al. : Chronic active hepatitis and giant multinucleated hepatocytes in adults treated with clometacin. Digestion 22:66–72, 1981

    Article  PubMed  CAS  Google Scholar 

  24. Al-Ashgar H, Al-Sohaibani F, Kagevi I, et al. : Autoimmune hepatitis induced by alpha-interferon therapy in a patient with chronic myeloid leukemia. Ann Saudi Med 22:73–74, 2002

    PubMed  Google Scholar 

  25. Pittau E, Bogliolo A, Tinti A, et al. : Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C. Clin Exp Rheumatol 15:415–419, 1997

    PubMed  CAS  Google Scholar 

  26. Sezaki H, Arase Y, Tsubota A, et al. : Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy. J Gastroenterol 38:493–500, 2003

    PubMed  Google Scholar 

  27. Reynolds TB, Peters RL, Yamada S: Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med 285:813–820, 1971

    Article  PubMed  CAS  Google Scholar 

  28. Reynolds TB: Laxative liver disease. In Drugs and the Liver. Gerok W, Sickling K (eds). Stuttgart: FK Schattauer-Verlag, 1975 pp 319–325

    Google Scholar 

  29. Goldstein GB, Lam KC, Mistilis SP: Drug-induced chronic hepatitis. Am J Dig Dis 18:177–184, 1973

    PubMed  CAS  Google Scholar 

  30. Cooksley WGE, Cowen AE, Powell LW: The incidence of oxyphenisatin ingestion in active chronic hepatitis: A prospective controlled study of 29 patients. Aust NZ J Med 3:124–128, 1973

    CAS  Google Scholar 

  31. Goldstein GB, Lam KC, Mistilis SP: Drug-induced chronic hepatitis. Am J Dig Dis 18:177–184, 1973

    PubMed  CAS  Google Scholar 

  32. Farrell GC: Drug-Induced Liver Disease. Edinburgh, Churchill Livingstone, 1994

  33. Scully LJ, Toze C, Sengar DP, et al. : Early-onset autoimmune hepatitis is associated with a C4A gene deletion. Gastroenterology 104:1478–1484, 1993

    PubMed  CAS  Google Scholar 

  34. Huang MJ, Liaw YF: Clinical associations between thyroid and liver diseases. J Gastroenterol Hepatol 10:344–350, 1995

    PubMed  CAS  Google Scholar 

  35. Giannoccaro F, Pace L, Antonaci S, et al. : Autoimmune hemolytic anemia in chronic hepatitis C virus infectioin treated with alpha-interferon: A therapy-related event or extra-hepatic immunologic manifestation?. Recenti Prog Med 90:592–594, 1999

    PubMed  CAS  Google Scholar 

  36. Pinol V, Cubiella J, Navasa M, et al. : Autoimmune hepatitis associated with thyroiditis and hypophysitis. A case report. Gastroenterol Hepatol 23:123–125, 2000

    CAS  Google Scholar 

  37. Ghilardi G, Gonvers JJ, So A: Hypothyroid myopathy as a complication of interferon alpha therapy for chronic hepatitis C virus infection. Br J Rheumatol 37:1349–1351, 1998

    PubMed  CAS  Google Scholar 

  38. Zeniya M: Thyroid disease in autoimmune liver diseases. Nippon Rinsho 57:1882–1887, 1999

    PubMed  CAS  Google Scholar 

  39. Cindoruk M, Yetkin I, Karakan T, et al. : The prevalence of autoimmune hepatitis in Hashimoto’s thyroiditis in a Turkish population. Acta Gastroenterol Belg 65:143–145, 2002

    PubMed  CAS  Google Scholar 

  40. Nordyke RA, Gilbert F Jr, Miyamoto LA, et al. : The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto’s thyroiditis. Arch Intern Med 153:862–865, 1993

    PubMed  CAS  Google Scholar 

  41. Poncin E, Silvain C, Touchard G, et al. : Papaverine-induced chronic liver disease. Gastroenterology 90:1051–1053, 1986

    PubMed  CAS  Google Scholar 

  42. Poupon R, Longchal C, Darnis F: Hepatite chronique associee a la prise prolongee de papaverine. Gastroenterol Clin Biol 2:305–309, 1978

    PubMed  CAS  Google Scholar 

  43. Chousterman M, Pulik M, Perie G: Hepatite a la papaverine. Nouv Presse Med 9:1899, 1980

    PubMed  CAS  Google Scholar 

  44. Desechalliers JP, Lerebours E, Tilly H, et al. : Hepatite chronique compliquee de cirrhose, due a la papaverine. Gastroenterol Clin Biol 5:818, 1981

    PubMed  CAS  Google Scholar 

  45. Pelli N, Setti M, Ceppa P, et al. : Autoimmune hepatitis revealed by atorvastatin. Eur J Gastroenterol Hepatol 15:921–924, 2003

    PubMed  Google Scholar 

  46. Graziadei IW, Obermoser GE, Sepp NT, et al. : Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis. Lupus 12:409–412, 2003

    PubMed  CAS  Google Scholar 

  47. Ben-Yahia M, Mavier P, Metreau JM, et al. : Chronic active hepatitis and cirrhosis induced by wild germander: Three cases. Gastroenterol Clin Biol 17:959–962, 1993

    PubMed  CAS  Google Scholar 

  48. Larrey D, Vial T, Pauurels A, et al. : Hepatitis after germander (Teucrium Chamaedrys) administration: Another instance of herbal medicine hepatotoxicity. Ann Intern Med 117:129–132, 1992

    PubMed  CAS  Google Scholar 

  49. Maddrey WC, Boitnott JK: Drug-induced chronic active hepatitis. In Autoimmune Liver Disease. Krawitt EL, Wiesner RH (eds). New York, Raven Press, 1991 pp 191–232

    Google Scholar 

  50. Stricker BHCh: Drug-Induced Hepatic INjury. Amsterdam, Elsevier, 1992

  51. Maggiore G, Larizza D, Lorini R, et al. : Propylthiouracil hepatotoxicity mimicking autoimmune chronic hepatitis in a girl. J Pediatr Gastroenterol 8:547–548, 1989

    CAS  Google Scholar 

  52. Cui B, Abe M, Hidata S, et al. : Autoimmune hepatitis associated with Graves’ disease. Intern Med 42:331–355, 2003

    PubMed  Google Scholar 

  53. Scully LJ, Clarke D, Barr RJ: Diclofenac-induced hepatitis in three cases with features of autoimmune chronic active hepatitis. Dig Dis Sci 38:744–751, 1993

    PubMed  CAS  Google Scholar 

  54. Banks AT, Zimmerman HJ, Ishak KG, et al. : Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the Food and Drug Administration as adverse reactions. Hepatology 22:820–827, 1995

    PubMed  CAS  Google Scholar 

  55. Sterling MJ, Kane M, Grace ND: Pemoline induced autoimmune hepatitis. Am J Gastroenterol 91:2233–2234, 1996

    PubMed  CAS  Google Scholar 

  56. Selimoglu MA, Ertekin V: Autoimmune hepatitis triggered by Brucella infection or doxycycline or both. Int J Clin Pract 57:639–641, 2003

    PubMed  CAS  Google Scholar 

  57. Babany G, Larrey D, Pessayre D, et al. : Chronic active hepatitis caused by benzarone. J Hepatol 5:332–335, 1987

    PubMed  CAS  Google Scholar 

  58. Bernard PH, Lamouliatte H, Le Bail B: Chronic active hepatitis associated with antinuclear antibodies induced by fenofibrate. Gastroenterol Clin Biol 18:1048, 1994

    PubMed  CAS  Google Scholar 

  59. Kamiyama T, Nouchi T, Kojima S, et al. : Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 92:703–704, 1997

    PubMed  CAS  Google Scholar 

  60. Murakami M, Kakizaki S, Takayama H, et al. : Autoimmune thyroid disease induced by interferon therapy. Nippon Rinsho 57:1779–1783, 1999

    PubMed  CAS  Google Scholar 

  61. Ward DL, Bing-You RG: Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: Screening and monitoring recommendations. Endocr Pract 7:52–58, 2001

    PubMed  CAS  Google Scholar 

  62. Dusheiko G: Side effects of alpha interferon in chronic hepatitis C. Hepatology 26:112–21S, 1997

    Google Scholar 

  63. Mekkakia-Benhabib C, Marcellin P, Colas-Linhart N, et al. : Natural history of dysthyroidism during interferoin treatment of chronic hepatitis C. Ann Endocrinol (Paris) 57:419–427, 1996

    CAS  Google Scholar 

  64. Garcia FG, Marco MA, Vela J, et al. : Hypothyroidism as a complication of the treatment of hepatitis C with interferon. Ann Intern Med 13:438–440, 1996

    Google Scholar 

  65. Martin-Vivaldi R, Nogueras F, Quintero D, et al. : Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment. with interferon. Rev Esp Enferm Dig 88:480–484, 1996

    CAS  Google Scholar 

  66. Rocco A, Gargano S, Provenzano A, et al. : Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection. Neuroendocrinol Lett 22:39–44, 2001

    PubMed  CAS  Google Scholar 

  67. Broussolle C, Steineur MP, Bailly F, et al. : Hepatitis C virus infection and thyroid diseases. Rev Med Int 20:766–773, 1999

    Article  CAS  Google Scholar 

  68. Marazuela M, Garcia-Buey L, Gonzalez-Fernandez B, et al. : Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol (Oxf) 44:635–642, 1999

    Google Scholar 

  69. Maccari S, Bassi C, Giovannini AG, et al. : A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy. Clin Rheumatol 10:452–454, 1991

    PubMed  CAS  Google Scholar 

  70. Martocchia A, Labbadia G, Paoletti V, et al. : Hashimoto’s disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease. Neuroendocrinol Lett 22:49–52, 2001

    PubMed  CAS  Google Scholar 

  71. Yoshikawa M, Sakamoto T, Mitoro A, et al. : Autoimmunity during alpha-interferon therapy for chronic hepatitis C. Gastroenterol Jpn 28:109–114, 1993

    Article  PubMed  Google Scholar 

  72. Okanoue T, Sakamoto S, Itoh Y, et al. : Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 25:283–291, 1996

    PubMed  CAS  Google Scholar 

  73. Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, et al. : Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med 158:1445–1448, 1998

    PubMed  CAS  Google Scholar 

  74. D’Hondt L, Delannoy A, Docqueir C: Hypothyroidism and arthritis during interferon therapy. Clin Rheumatol 12:415–417, 1993

    PubMed  CAS  Google Scholar 

  75. Morisco F, Mazziotti G, Rotondi M, et al. : Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C. Dig Liver Dis 33:247–253, 2001

    PubMed  CAS  Google Scholar 

  76. Shimizu M, Hirokawa M, Manabe T, et al. : Lithium associated autoimmune thyroiditis. J Clin Pathol 50:172–174, 1997

    PubMed  CAS  Google Scholar 

  77. Gudbjornsson B, Kristinsson A, Geirsson G, et al. : Painful autoimmune thyroiditis occurring on amiadarone therapy. Acta Med Scand 221:219–220, 1987

    Article  PubMed  CAS  Google Scholar 

  78. Nishiyama S, Matsukura M, Fujimoto S, et al. : Reports of two cases of autoimmune thyroiditis while receiving anticonvulsant therapy. Eur J Pediatr 140:116–117, 1983

    PubMed  CAS  Google Scholar 

  79. Takorabet L, Ropars A, Stasiuk L, et al. : Phenothiazine-induced increase in thyroid autoantigens and costimulatory molecules on thyroid cells: A pathophysiological mechanism for drug-induced autoimmunity?. Clin Exp Immunol 111:415–421, 1998

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Georgetown University Medical Center, 3800 Reservoir Road, NW, Washington, DC, 20007, USA

    Omar Khokhar MD, Christopher Gange MD & James Lewis MD

  2. Division of Endocrinology, Department of Medicine, Georgetown University Medical Center, 3800 Reservoir Road, NW, Washington, DC, 20007, USA

    Stephen Clement MD

Authors
  1. Omar Khokhar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher Gange MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephen Clement MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James Lewis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Omar Khokhar MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khokhar, O., Gange, C., Clement, S. et al. Autoimmune Hepatitis and Thyroiditis Associated with Rifampin and Pyrazinamide Prophylaxis: An Unusual Reaction. Dig Dis Sci 50, 207–211 (2005). https://doi.org/10.1007/s10620-005-1302-0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-1302-0

KEY WORDS:

Search

Navigation